United States Biotechnology & Medical Research

Inovio Pharmaceuticals Inc (INO)

Track

Inovio Pharmaceuticals Inc. has recorded no insider trading activity within the last three months. The most recent transactions occurred in June 2023, consisting of planned and proposed sales by company directors. Historical data indicates a pattern of scheduled divestments by various insiders over the preceding years.
Ticker: INO Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Inovio Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Proposed sale 5 Jun 2023
Value US$2,019,124.19 | Price 70.93 | Shares 69,690
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-06-05 2023-06-05 PrS Proposed sale
LOTA ZOTH

Director

Non-Executive Director
69,690
70.93
US$2,019,124 		69,690 70.93 US$2,019,124
2023-06-05 2023-06-05 PlS Planned sale
Zoth Lota S.
Non-Executive Director
94,362 +26.2%
93.43
US$3,033,730 		94,362 +26.2% 93.43 US$3,033,730
2023-03-13 2023-03-13 PlS Planned sale
2.4
Weiner David B.
Non-Executive Director
74,886 +2.3%
407.42
US$774,276 		74,886 +2.3% 407.42 US$774,276
2023-02-28 2023-02-27 PlS Planned sale
2.4
Weiner David B.
Non-Executive Director
11,668 -1.3%
1.28
US$14,935 		11,668 -1.3% 1.28 US$14,935
2022-08-11 2022-08-11 PlS Planned sale
2.4
Weiner David B.
Non-Executive Director
11,875 -1.3%
2.66
US$31,588 		11,875 -1.3% 2.66 US$31,588
2022-07-20 2022-07-20 PlS Planned sale
2.9
BENITO SIMON X
Non-Executive Director
2,000 -2.6%
2.25
US$4,500 		2,000 -2.6% 2.25 US$4,500
2022-05-17 2022-05-16 PlS Planned sale
2.4
Weiner David B.
Non-Executive Director
9,000 -1.0%
1.95
US$17,550 		9,000 -1.0% 1.95 US$17,550
2022-05-17 2022-05-16 PlS Planned sale
Zoth Lota S.
Non-Executive Director
3,600 -8.4%
1.98
US$7,128 		3,600 -8.4% 1.98 US$7,128
2022-03-17 2022-03-16 PlS Planned sale
2.9
BENITO SIMON X
Non-Executive Director
2,000 -3.4%
3.16
US$6,320 		2,000 -3.4% 3.16 US$6,320
2022-03-14 2022-03-14 PlS Planned sale
2.4
Weiner David B.
Non-Executive Director
4,083 -0.5%
3.20
US$13,066 		4,083 -0.5% 3.20 US$13,066
2022-03-09 2022-03-09 PlS Planned sale
2.4
Weiner David B.
Non-Executive Director
4,083 -0.5%
3.33
US$13,596 		4,083 -0.5% 3.33 US$13,596
2022-01-21 2022-01-19 PlS Planned sale
2.9
BENITO SIMON X
Non-Executive Director
2,000 -3.4%
4.27
US$8,540 		2,000 -3.4% 4.27 US$8,540
2022-01-05 2022-01-05 PlS Planned sale
Zoth Lota S.
Non-Executive Director
961 -3.7%
5.01
US$4,815 		961 -3.7% 5.01 US$4,815
2021-08-11 2021-08-09 PlS Planned sale
2.2
Humeau Laurent

Chief Scientific Officer

Officer
10,317 -13.1%
9.15
US$94,401 		10,317 -13.1% 9.15 US$94,401
2021-06-11 2021-06-09 PlS Planned sale
KIES PETER

CFO

Officer
33,750 -20.5%
10.01
US$337,838 		33,750 -20.5% 10.01 US$337,838
2021-06-11 2021-06-09 PlS Planned sale
Shea Jacqueline Elizabeth

Chief Operating Officer

Officer
38,535 -64.1%
10.01
US$385,735 		38,535 -64.1% 10.01 US$385,735
2021-06-11 2021-06-09 PlS Planned sale
2.2
Humeau Laurent

Chief Scientific Officer

Officer
10,318 -11.6%
9.07
US$93,584 		10,318 -11.6% 9.07 US$93,584
2021-05-17 2021-05-17 PlS Planned sale
2.4
Weiner David B.
Non-Executive Director
3,045 -0.4%
6.62
US$20,158 		3,045 -0.4% 6.62 US$20,158
2021-04-21 2021-04-21 PlS Planned sale
2.4
Weiner David B.
Non-Executive Director
4,083 -0.5%
8.54
US$34,869 		4,083 -0.5% 8.54 US$34,869
2021-04-21 2021-04-21 PlS Planned sale
2.4
Weiner David B.
Non-Executive Director
22,500 -2.6%
8.57
US$192,825 		22,500 -2.6% 8.57 US$192,825
2021-04-16 2021-04-16 PlS Planned sale
2.9
BENITO SIMON X
Non-Executive Director
2,000 -3.7%
8.75
US$17,500 		2,000 -3.7% 8.75 US$17,500
2021-03-26 2021-03-26 PlS Planned sale
Shea Jacqueline Elizabeth

Chief Operating Officer

Officer
4,710 -7.3%
8.97
US$42,249 		4,710 -7.3% 8.97 US$42,249
2021-03-16 2021-03-16 PlS Planned sale
2.9
BENITO SIMON X
Non-Executive Director
2,000 -3.7%
10.41
US$20,820 		2,000 -3.7% 10.41 US$20,820
2021-03-12 2021-03-12 PlS Planned sale
Shea Jacqueline Elizabeth

Chief Operating Officer

Officer
16,881 -23.3%
10.06
US$169,823 		16,881 -23.3% 10.06 US$169,823
2021-03-09 2021-03-09 PlS Planned sale
2.4
Weiner David B.
Non-Executive Director
3,500 -0.4%
9.60
US$33,601 		3,500 -0.4% 9.60 US$33,601
2021-03-09 2021-03-08 PlS Planned sale
2.4
Weiner David B.
Non-Executive Director
3,500 -0.4%
9.18
US$32,135 		3,500 -0.4% 9.18 US$32,135
2021-02-18 2021-02-16 PlS Planned sale
2.9
BENITO SIMON X
Non-Executive Director
2,000 -3.7%
14.68
US$29,360 		2,000 -3.7% 14.68 US$29,360
2021-02-03 2021-02-03 PlS Planned sale
3.0
Kim Jong Joseph

Chief Executive Officer

Executive Director
62,500 -5.5%
14.24
US$890,000 		62,500 -5.5% 14.24 US$890,000
2021-02-03 2021-02-01 PlS Planned sale
Shea Jacqueline Elizabeth

Chief Operating Officer

Officer
5,960 -13.4%
15.00
US$89,400 		5,960 -13.4% 15.00 US$89,400
2021-02-03 2021-02-01 PlS Planned sale
Shea Jacqueline Elizabeth

Chief Operating Officer

Officer
22,376 -33.5%
15.06
US$336,983 		22,376 -33.5% 15.06 US$336,983
2021-02-03 2021-02-01 PlS Planned sale
3.0
Kim Jong Joseph

Chief Executive Officer

Executive Director
100,000 -8.5%
15.00
US$1,500,000 		100,000 -8.5% 15.00 US$1,500,000
2021-01-29 2021-01-28 PlS Planned sale
Shea Jacqueline Elizabeth

Chief Operating Officer

Officer
16,713 -27.3%
12.04
US$201,225 		16,713 -27.3% 12.04 US$201,225
2021-01-29 2021-01-27 PlS Planned sale
Shea Jacqueline Elizabeth

Chief Operating Officer

Officer
5,960 -50.0%
12.04
US$71,758 		5,960 -50.0% 12.04 US$71,758
2021-01-29 2021-01-27 PlS Planned sale
Shea Jacqueline Elizabeth

Chief Operating Officer

Officer
22,376 -65.2%
12.01
US$268,736 		22,376 -65.2% 12.01 US$268,736
2021-01-15 2021-01-15 PlS Planned sale
KIES PETER

CFO

Officer
30,000 -20.1%
10.02
US$300,558 		30,000 -20.1% 10.02 US$300,558
2021-01-05 2021-01-05 PlS Planned sale
Zoth Lota S.
Non-Executive Director
961 -5.9%
9.48
US$9,110 		961 -5.9% 9.48 US$9,110
2021-01-05 2021-01-04 PlS Planned sale
2.9
BENITO SIMON X
Non-Executive Director
2,750 -5.1%
9.00
US$24,750 		2,750 -5.1% 9.00 US$24,750
2020-12-17 2020-12-15 PlS Planned sale
KIES PETER

CFO

Officer
20,000 -14.4%
10.69
US$213,706 		20,000 -14.4% 10.69 US$213,706
2020-12-17 2020-12-15 PlS Planned sale
2.4
Weiner David B.
Non-Executive Director
17,500 -2.1%
10.71
US$187,352 		17,500 -2.1% 10.71 US$187,352
2020-11-12 2020-11-10 PlS Planned sale
2.2
Humeau Laurent

Chief Scientific Officer

Officer
19,466 -44.3%
9.75
US$189,794 		19,466 -44.3% 9.75 US$189,794
2020-08-12 2020-08-10 PlS Planned sale
2.2
Humeau Laurent

Chief Scientific Officer

Officer
19,467 -30.7%
19.06
US$371,004 		19,467 -30.7% 19.06 US$371,004
2020-07-31 2020-07-30 PlS Planned sale
3.0
Kim Jong Joseph

Chief Executive Officer

Executive Director
100,000 -7.8%
21.13
US$2,113,450 		100,000 -7.8% 21.13 US$2,113,450
2020-07-17 2020-07-15 PlS Planned sale
KIES PETER

CFO

Officer
35,000 -22.7%
24.95
US$873,208 		35,000 -22.7% 24.95 US$873,208
2020-07-02 2020-06-30 PlS Planned sale
KIES PETER

CFO

Officer
35,000 -22.7%
26.50
US$927,500 		35,000 -22.7% 26.50 US$927,500
2020-06-24 2020-06-22 PlS Planned sale
2.2
Humeau Laurent

Chief Scientific Officer

Officer
19,467 -23.5%
14.70
US$286,165 		19,467 -23.5% 14.70 US$286,165
2020-05-20 2020-05-20 S Sale
2.9
BENITO SIMON X
Non-Executive Director
8,750 -14.5%
15.95
US$139,594 		8,750 -14.5% 15.95 US$139,594
2020-05-12 2020-05-11 PlS Planned sale
2.4
Weiner David B.
Non-Executive Director
2,404 -0.3%
11.84
US$28,463 		2,404 -0.3% 11.84 US$28,463
2020-03-12 2020-03-12 PlS Planned sale
2.4
Weiner David B.
Non-Executive Director
3,500 -0.4%
11.14
US$38,990 		3,500 -0.4% 11.14 US$38,990
2020-03-12 2020-03-10 PlS Planned sale
2.4
Weiner David B.
Non-Executive Director
3,500 -0.4%
9.32
US$32,620 		3,500 -0.4% 9.32 US$32,620
2020-03-09 2020-03-09 PlS Planned sale
2.4
Weiner David B.
Non-Executive Director
3,500 -0.4%
18.00
US$63,000 		3,500 -0.4% 18.00 US$63,000
2020-01-13 2020-01-13 B Purchase
3.0
Kim Jong Joseph

Chief Executive Officer

Executive Director
22,500 +2.1%
3.11
US$69,975 		22,500 +2.1% 3.11 US$69,975
2019-09-04 2019-08-30 B Purchase
2.2
Humeau Laurent

Chief Scientific Officer
4,500 +9.8%
2.22
US$9,990 		4,500 +9.8% 2.22 US$9,990
2019-08-02 2019-08-01 PlS Planned sale Weiner David B. Non-Executive Director
16,352 -2.0%
2.72
US$44,477 		16,352 -2.0% 2.72 US$44,477
2019-06-05 2019-06-05 B Purchase
2.2
Humeau Laurent

Chief Scientific Officer
20,000 +77.4%
2.50
US$50,000 		20,000 +77.4% 2.50 US$50,000
2019-06-04 2019-06-03 S Sale
3.0
Kim Jong Joseph

Chief Executive Officer

Executive Director
296,705 -26.7%
2.31
US$684,736 		296,705 -26.7% 2.31 US$684,736
2019-06-04 2019-06-03 S Sale
3.0
Kim Jong Joseph

Chief Executive Officer

Executive Director
832,848 -43.6%
2.30
US$1,914,468 		832,848 -43.6% 2.30 US$1,914,468
2019-06-04 2019-05-31 S Sale
3.0
Kim Jong Joseph

Chief Executive Officer

Executive Director
500,000 -31.0%
2.40
US$1,200,800 		500,000 -31.0% 2.40 US$1,200,800
2019-06-04 2019-05-31 S Sale
3.0
Kim Jong Joseph

Chief Executive Officer

Executive Director
500,000 -20.7%
2.44
US$1,217,650 		500,000 -20.7% 2.44 US$1,217,650
2019-05-23 2019-05-21 S Sale
3.0
Kim Jong Joseph

Chief Executive Officer

Executive Director
100,000 -4.0%
3.31
US$331,000 		100,000 -4.0% 3.31 US$331,000
2019-05-17 2019-05-16 PlS Planned sale
3.0
Kim Jong Joseph

Chief Executive Officer

Executive Director
61,212 -3.7%
3.50
US$214,242 		61,212 -3.7% 3.50 US$214,242
2019-05-17 2019-05-15 PlS Planned sale
3.0
Kim Jong Joseph

Chief Executive Officer

Executive Director
75,556 -4.3%
3.50
US$264,446 		75,556 -4.3% 3.50 US$264,446
2018-11-30 2018-11-29 S Sale KIES PETER

CFO

Officer
10,001 -13.9%
5.28
US$52,805 		10,001 -13.9% 5.28 US$52,805
2018-09-14 2018-09-12 S Sale Kim Jong Joseph

Chief Executive Officer

Executive Director
49,060 -2.1%
5.37
US$263,452 		49,060 -2.1% 5.37 US$263,452
2018-07-11 2018-07-10 S Sale KIES PETER

CFO

Officer
10,000 -13.9%
4.45
US$44,500 		10,000 -13.9% 4.45 US$44,500
2018-07-11 2018-07-09 S Sale KIES PETER

CFO

Officer
25,000 -25.7%
4.43
US$110,750 		25,000 -25.7% 4.43 US$110,750
2018-04-19 2018-04-16 S Sale Weiner David B.
9,000 -1.2%
4.91
US$44,203 		9,000 -1.2% 4.91 US$44,203
2018-04-13 2018-04-13 S Sale Kim Jong Joseph

Chief Executive Officer

Executive Director
107,500 -4.5%
5.06
US$543,412 		107,500 -4.5% 5.06 US$543,412
2018-04-13 2018-04-12 S Sale BENITO SIMON X
3,750 -11.9%
5.23
US$19,619 		3,750 -11.9% 5.23 US$19,619
2018-04-13 2018-04-12 S Sale Kim Jong Joseph

Chief Executive Officer

Executive Director
103,750 -4.3%
5.14
US$533,140 		103,750 -4.3% 5.14 US$533,140
2017-05-26 2017-05-25 S Sale
2.4
Weiner David B.
Non-Executive Director
8,000 -1.1%
8.00
US$64,016 		8,000 -1.1% 8.00 US$64,016
2017-04-03 2017-03-31 S Sale Kim Jong Joseph

Chief Executive Officer

Executive Director
73,590 -3.4%
6.57
US$483,773 		73,590 -3.4% 6.57 US$483,773
2017-04-03 2017-03-30 S Sale Kim Jong Joseph

Chief Executive Officer

Executive Director
73,590 -3.4%
6.51
US$478,710 		73,590 -3.4% 6.51 US$478,710
2017-03-28 2017-03-27 B Purchase COLLINS MORTON Non-Executive Director
21,300 +74.2%
6.25
US$133,189 		21,300 +74.2% 6.25 US$133,189
2016-08-30 2016-08-29 S Sale Sardesai Niranjan

Chief Operating Officer

Officer
21,800 -31.0%
9.30
US$202,733 		21,800 -31.0% 9.30 US$202,733
2016-06-29 2016-06-28 B Purchase COLLINS MORTON Non-Executive Director
10,000 +7.6%
9.13
US$91,309 		10,000 +7.6% 9.13 US$91,309
Explore more

More insider trading research around Inovio Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America